You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股收評:恒指升0.77%,CXO強勢上升,餐飲、啤酒等消費股跌幅居前

9月12日,三大指數午後回落,但全天仍維持升勢。截止收盤,恒指、國指分別上升0.77%及0.58%,恒生科技指數升0.71%。

盤面上,大型科技股普升,美團、京東、阿里巴巴升超2%,網易、百度升超1%,騰訊收紅;CXO板塊升幅居前,花旗稱藥明康德和藥明生物股價被低估;建材水泥股探底回升,海螺水泥放量升超5%;保險業第三個“國十條”激活萬億養老金融市場,內險股普升;濠賭股、港口及海運股、紙業股、水務股、內房股多數上升。另一方面,教育股全天維持低迷行情,家電股、餐飲股、啤酒股等消費股集體萎靡,華潤啤酒跌3.5%,海底撈跌2.65%市值跌破700億港元。

具體來看,

大型科技股普升,美團、京東、阿里巴巴升超2%,網易、百度升超1%,騰訊收紅。

建材水泥股升幅居前,海螺水泥升超5%,金隅水泥、東吳水泥、華新水泥升超3%,西部水泥、華潤建材科技升超2%。消息面上,為加快推進擴大全國碳排放權交易市場覆蓋範圍工作,生態環境部編制形成了《全國碳排放權交易市場覆蓋水泥、鋼鐵、電解鋁行業工作方案(徵求意見稿)》,現公開徵求意見。

醫藥外包概念延續升勢,藥明康德升近6%,凱萊英升4.33%,藥明生物、金斯瑞生物科技升超3%。花旗最新發表報吿稱,美眾院通過《生物安全法案》,目前未清楚美參議院會否採用眾議院版本的《生物安全法案》或另一個版本,或對《生物安全法案》附加更大法案。該行相信藥明康德和藥明生物股價被低估,但不確定性影響投資者對CXO板塊信心。

博彩股持續上行,亞博科技控股升25%,新濠國際發展、金沙中國、澳博控股升超2%,永利澳門、銀河娛樂升超1%。中金公司指出,受惠於暑期或帶動訪客量上升及新物業的持續放量,澳門8月總博彩收入同比增長14.8%至198億澳門元。該行預測,9月澳門總博彩收入可望達到173億至188億澳門元,對應日均博彩收入為5.75億至6.25億澳門元之間。

港口航運股普升,海豐國際升4.11%,中遠海控升超3%,遠航港口、天津港發展、遼港股份、招商局港口升超1%。

紙業股上升,玖龍紙業升3.65%,晨鳴紙業升2.08%,陽光紙業升0.48%。

保險股造好,友邦保險升3.67%,中國平安、眾安在線升超1%,中國人壽、中國太平跟升。

內地教育股跌幅靠前,創聯控股跌12%,天立國際控股跌8.51%,光正教育跌7.5%,成實外教育、中國科培跌超3%。

餐飲股、啤酒股等消費股表現萎靡,海倫司跌8.16%,呷哺呷哺跌6.17%,華潤啤酒跌3.49%,海底撈跌2.65%市值跌破700億港元。

內地物業管理股表現較弱,金科服務跌超15%,弘陽服務跌超11%,卓越商企服務跌4.1%,寶龍商業、綠城管理控股跌超2%。

個股方面:

美團拉昇升2.43%,近日連升收復此前跌幅走出反轉行情。消息面上,公司昨日回購420.22萬股,每股回購價格為116.7-119.8港元,共耗資約5億港元。

華晨中國跌超12%,吳小安辭任董事會主席,聯交所此前譴責公司及三名前任董事。

今日,南向資金淨買入30.75億港元,其中滬股通(滬)淨買入12.16億港元,港股通(深)淨買入18.59億港元。

展望後市,國信證券指出,港股在二季報期間大約有三分之二的公司業績呈現上修特徵,這為後續大盤上行提供了較為堅實的基礎。判斷港股大概率不再會創新低,即以8月的低點16441為低點的反轉行情已經開始。

板塊方面或可聚焦:1)高股息:高股息在8月有顯著回落,如電信、資源、公用事業、銀行已經形成了一定幅度調整,目前已具備吸引力;2)互聯網龍頭公司:幾家互聯網龍頭公司中報業績表現不錯,且持續回購,提升股東回報比例,在降息週期中也值得關注。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account